Liberty Health Sciences (CSE: LHS) has seen shareholders granted approval for the previously announced acquisition by that of Ayr Wellness (CSE: AYR.u). The transaction will see the company acquired in an all-stock transaction initially valued at $372 million.
The transaction received approval from a total of 95.08% of Liberty securityholders present at the meeting, and 94.80% of Liberty shareholders. In total, 57.19% of Liberty shares voted at the meeting, representing 204.5 million shares.
The company will now proceed with the finalization of the arrangement, which is still subject to approval of the CSE, regulatory and court approvals, along with customary conditions of closing. While the company did not reiterate the target of the first quarter of 2021 for the closing of the arrangement, the firm did indicate that it will look to close the transaction “as quickly as possible.”
Under the terms of the arrangement, Liberty shareholders are to receive 0.03683 subordinate voting shares or restricted voting shares for each Liberty Health share held, which implied a valuation of $1.05 per share at the time of announcement. Given the current price of $40.16 for Ayr Wellness, that figure has risen to approximately $1.48 at the time of writing.
Liberty Health Sciences last traded at $1.40 on the CSE.
Information for this briefing was found via Sedar and Liberty Health Sciences. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.